ASO tominersen for Huntington’s disease in Phase III trials VJNeurology 2:20 3 years ago 766 Скачать Далее
Ongoing trials with importance for Huntington’s disease VJNeurology 4:24 2 years ago 904 Скачать Далее
Moving forwards after disappointing data in the Huntington’s disease space VJNeurology 1:05 1 year ago 137 Скачать Далее
Ionis partner Roche will evaluate Thommassen's treatment of Huntington's disease in a new phase II Tech Move 1:17 2 years ago 36 Скачать Далее
Update on huntingtin-lowering strategies under investigation for Huntington’s disease VJNeurology 4:14 1 year ago 728 Скачать Далее
HDYO Research Video Series: An Update on the Roche GENERATION-HD1 Trial HDYO 3:51 2 years ago 130 Скачать Далее
RESEARCH WEBINAR: Roche Presents GENERATION-HD1 Data Huntington's Disease Society of America 1:35:07 3 years ago 1 938 Скачать Далее
Huntington Lowering Trial: Prof Sarah Tabrizi & Roche Update: Dr Scott Schobel HDYO 59:24 3 years ago 705 Скачать Далее
WEBINAR: Phase 2 GENERATION HD2 clinical trial is open now European Huntington Association 49:21 1 year ago 514 Скачать Далее
Keynote - HD Research Update from Dr. Claassen (Vanderbilt) - UF Huntington Disease Symposium Norman Fixel Institute for Neurological Diseases 52:52 3 years ago 650 Скачать Далее
Research update | Huntington's disease Huntington's Disease Association 32:55 1 year ago 1 597 Скачать Далее
E14.2 Therapeutic advances in Huntingtons disease with relevance to other repeat expansion disorders European Society of Human Genetics 24:16 4 years ago 182 Скачать Далее
The impact of wild-type HTT suppression on brain function VJNeurology 0:50 1 year ago 344 Скачать Далее
GENERATION HD1 - what happened and what does it mean? European Huntington Association 37:57 3 years ago 1 191 Скачать Далее
Daniel Claassen, MD, MS: Allele-Selective Therapy for Huntington Disease NeurologyLive 3:19 4 years ago 189 Скачать Далее
A Message from Roche about the GENERATION-HD1 Trial News Huntington's Disease Society of America 2:48 3 years ago 1 710 Скачать Далее
